GNCC Capital, Inc. GNCC Capital, Inc.

GNCC Capital, Inc.

GNCP

Rank in Stocks #34092
GNCC Capital, Inc., operating through its subsidiary BioCann Pharma S.A.S.,... GNCC Capital, Inc., operating through its subsidiary BioCann Pharma S.A.S., specializes in the production and marketing of pharmaceutical-grade CBD oils derived from cannabis. These products are distributed via established networks throughout Colombia and across the broader Latin American market. The parent company's headquarters are located in Las Vegas, Nevada.
Share Price
$0.000001
Last synced: 2026-11-09
Market Cap
$69.92K
Change (1 day)
-98.00%
Change (1 year)
-98.00%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Category

Basic Materials
EPS for GNCC Capital, Inc. (GNCP)
EPS as of December 2021 TTM: 0.00
According to GNCC Capital, Inc.'s latest financial reports, its current EPS (TTM) is 0.00. At the end of 2021 the company had an EPS of 0.00, equal to its 2020 EPS of 0.00.
EPS history for GNCC Capital, Inc. from 2016 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) 0.00 0.00%
2021 0.00 0.00%
2020 0.00 -100.00%
2019 0.00 -50.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
EPS for similar companies or competitors

Questions about GNCC Capital, Inc.'s earnings per share (EPS)

What was GNCC Capital, Inc.'s earnings per share (EPS) in 2021?

In 2021, GNCC Capital, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2020.

How has GNCC Capital, Inc.'s earnings per share (EPS) changed since 2016?

From 2016 to 2021, GNCC Capital, Inc.'s earnings per share (EPS) was highest in 2021 (0.00) and lowest in 2021 (0.00).

How does GNCC Capital, Inc.'s earnings per share (EPS) compare with similar companies?

GNCC Capital, Inc.'s earnings per share (EPS) (0.00) is lower than that of all 5 similar companies listed above. The highest among them is Agnico Eagle Mines Limited, with $12.29.